1. Abe R.Y., Diniz-Filho A., Zangwill L.M., Gracitelli C.P., Marvasti A.H., Weinreb R.N., Baig S., Medeiros F.A. The relative odds of progressing by structural and functional tests in glaucoma. Invest. Ophthalmol. Vis. Sci. 2016; 57 (9): 421–428. doi: 10.1167/iovs.15-18940
2. Aptel F., Bron A.M., Lachkar Y., Schweitzer C. Change in visual field progression following treatment escalation in primary open-angle glaucoma. J. Glaucoma. 2017; 26 (10): 875–880. doi: 10.1097/IJG.0000000000000748
3. Blumberg D., Skaat A., Liebmann J.M. Emerging risk factors for glaucoma onset and progression. Prog. Brain Res. 2015; 221: 81–101. doi: 10.1016/bs.pbr.2015.04.007
4. Perdicchi A., Abdolrahimzadeh S., Cutini A., Ciarnella A., Scuderi G.L. Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma. Clin. Ophthalmol. 2016; 10: 1647–1651. doi: 10.2147/OPTH.S113995
5. De Moraes C.G., Liebmann J.M., Levin L.A. Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma. Prog. Retin. Eye Res. 2017; 56: 107–147. doi: 10.1016/j.preteyeres.2016.10.001
6. De Moraes C.G., Liebmann J.M., Greenfield D.S., Gardiner S.K., Ritch R., Krupin T. Risk factors for visual field progression in the low-pressure glaucoma treatment study. Am. J. Ophthalmol. 2012; 154 (4): 702–711. doi: 10.1016/j.ajo.2012.04.015
7. De Moraes C.G., Juthani V.J., Liebmann J.M., Teng C.C., Tello C., Susanna R.Jr., Ritch R. Risk factors for visual field progression in treated glaucoma. Arch. Ophthalmol. 2011; 129 (5): 562–569. doi: 10.1001/archophthalmol.2011.72
8. Gardiner S.K., Crabb D.P. Frequency of testing for detecting visual field progression. Br. J. Ophthalmol. 2002; 86 (5): 560–564. doi: 10.1136/bjo.86.5.560
9. Heijl A., Buchholz P., Norrgren G., Bengtsson B. Rates of visual field progression in clinical glaucoma care. Acta Ophthalmol. 2013; 91 (5): 406–412. doi: 10.1111/j.1755-3768.2012.02492.x
10. Holmin C., Krakau C. Regression analysis of the central visual field in chronic glaucoma cases. Acta Ophthalmol. 2009; 60 (2): 267–274. doi: 10.1111/j.1755-3768.1982.tb08381.x
11. King A.J., Fernie G., Azuara-Blanco A., Burr J.M., Garway-Heath T., Sparrow J.M., Vale L., Hudson J., MacLennan G., McDonald A., Barton K., Norrie J. Treatment of advanced glaucoma study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol. Br. J. Ophthalmol. 2018; 102 (7): 922–928. doi: 10.1136/bjophthalmol-2017-310902
12. Kourkoutas D., Buys Y.M., Flanagan J.G., Karamaounas N., Georgopoulos G., Iliakis E. Moschos M.M., Trope G.E.. Clinical significance of optic disc progression by topographic change analysis maps in glaucoma: an 8-year follow-up study. J. Ophthalmol. 2014: 1–12. doi: 10.1155/2014/987389
13. Leung C.K., Yu M., Weinreb R.N., Ye C., Liu S., Lai G., Lam D.S. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a prospective analysis of age-related loss. Ophthalmology. 2012; 119 (4): 731–737. doi: 10.1016/j.ophtha.2011.10.010
14. Memarzadeh F., Ying-Lai M., Chung J., Azen S., Varma R. Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study. Invest. Ophthalmol. Vis. Sci. 2010; 51 (6): 2872–2878. doi: 10.1167/iovs.08-2956
15. Nouri-Mahdavi K., Zarei R., Caprioli J. Influence of visual field testing frequency on detection of glaucoma progression with trend analyses. Arch. Ophthalmol. 2011; 129 (12): 1521–1528. doi: 10.1001/archophthalmol.2011.224
16. Peters D., Bengtsson B., Heijl A. Factors associated with lifetime risk of open-angle glaucoma blindness. Acta Ophthalmol. 2014; 92 (5): 421-432. doi: 10.1111/aos.12203
17. Saunders L.J., Russell R.A., Kirwan J.F., McNaught A.L., Crabb D.P. Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime. Invest. Ophthalmol. Vis. Sci. 2014; 55 (1): 102–109. doi: 10.1167/iovs.13-13006
18. Spry P.G., Johnson C.A., McKendrick A.M., Turpin A. Variability components of standard automated perimetry and frequency doubling technology perimetry. Invest. Ophthalmol. Vis. Sci. 2001; 42 (6): 1404–1410.
19. Terminology and guidelines for glaucoma. Savona: PubliComm, 2014. 156 p.
20. The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 2000; 130 (4): 429–440. doi: 10.1016/s0002-9394(00)00538-9
21. Weinreb R.N., Aung T., Medeiros F.A. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014; 311 (18): 1901. doi: 10.1001/jama.2014.3192
22. Yu M., Lin C., Weinreb R.N., Lai G., Chiu V., Leung C.K. Risk of visual field progression in glaucoma patients with progressive retinal nerve fiber layer thinning. Ophthalmology. 2016; 123 (6): 1201–1210. doi: 10.1016/j.ophtha.2016.02.017